Search Results - "Ni, Yuchao"

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma by Sun, Guangxi, Chen, Junru, Liang, Jiayu, Yin, Xiaoxue, Zhang, Mengni, Yao, Jin, He, Ning, Armstrong, Cameron M., Zheng, Linmao, Zhang, Xingming, Zhu, Sha, Sun, Xiaomeng, Yang, Xiaoxia, Zhao, Wanbin, Liao, Banghua, Pan, Xiuyi, Nie, Ling, Yang, Ling, Chen, Yuntian, Zhao, Jinge, Zhang, Haoran, Dai, Jindong, Shen, Yali, Liu, Jiyan, Huang, Rui, Liu, Jiandong, Wang, Zhipeng, Ni, Yuchao, Wei, Qiang, Li, Xiang, Zhou, Qiao, Huang, Haojie, Liu, Zhenhua, Shen, Pengfei, Chen, Ni, Zeng, Hao

“…TFE3 -translocation renal cell carcinoma ( TFE3 -tRCC) is a rare and heterogeneous subtype of kidney cancer with no standard treatment for advanced disease. We…”
Get full text

Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma by Sun, Guangxi, Zhang, Xingming, Liang, Jiayu, Pan, Xiuyi, Zhu, Sha, Liu, Zhenhua, Armstrong, Cameron M, Chen, Jianhui, Lin, Wei, Liao, Banghua, Lin, Tianhai, Huang, Rui, Zhang, Mengni, Zheng, Linmao, Yin, Xiaoxue, Nie, Ling, Shen, Pengfei, Zhao, Jinge, Zhang, Haoran, Dai, Jindong, Shen, Yali, Li, Zhiping, Liu, Jiyan, Chen, Junru, Liu, Jiandong, Wang, Zhipeng, Zhu, Xudong, Ni, Yuchao, Qin, Dan, Yang, Ling, Chen, Yuntian, Wei, Qiang, Li, Xiang, Zhou, Qiao, Huang, Haojie, Yao, Jin, Chen, Ni, Zeng, Hao

“…Fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) is a rare but lethal subtype of RCC. Little is known about the genomic profile of…”
Get full text

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P) by Zhu, Sha, Zhao, Jinge, Nie, Ling, Yin, Wenlian, Zhang, Yaowen, Zhao, Fengnian, Ni, Yuchao, Zhang, Xingming, Wang, Zhipeng, Dai, Jindong, Liu, Zhenhua, Chen, Junru, Zeng, Yuhao, Wang, Zilin, Sun, Guangxi, Liang, Jiayu, Zhao, Xiaochen, Zhu, Xudong, Tao, Ronggui, Yang, Jiyu, He, Ben, Chen, Ni, Shen, Pengfei, Zeng, Hao

“…Abstract Background Intraductal carcinoma of the prostate (IDC-P) is a subtype of prostate cancer featured by poor prognosis. Previous studies suggested IDC-P…”
Get full text

Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bayesian Network Meta-Analysis by Chen, Junru, Ni, Yuchao, Sun, Guangxi, Liao, Banghua, Zhang, Xingming, Zhao, Jinge, Zhu, Sha, Wang, Zhipeng, Shen, Pengfei, Zeng, Hao

“…Objective: To compare the efficacy and safety of current systemic combination therapies for patients with mHSPC and help select candidates for optimal…”
Get full text

Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone by Yang, Zhenyu, Ni, Yuchao, Zhao, Diwei, Zhang, Yijun, Wang, Jun, Jiang, Lijuan, Chen, Dong, Wu, Zhiming, Wang, Yanjun, He, Liru, Shi, Yanxia, Zhou, Fangjian, Zeng, Hao, Li, Yonghong

“…Abstract Background To assess the efficacies and potential predictors of a corticosteroid switch in metastatic castration-resistant prostate cancer (mCRPC)…”
Get full text

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis by Wang, Zhipeng, Ni, Yuchao, Chen, Junru, Sun, Guangxi, Zhang, Xingming, Zhao, Jinge, Zhu, Xudong, Zhang, Haoran, Zhu, Sha, Dai, Jindong, Shen, Pengfei, Zeng, Hao

“…The optimal treatment for patients with high-risk prostate cancer (PCa) remains a debate and selection of patients to receive proper therapy is still an…”
Get full text

Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma by Zhao, Junjie, Tang, Yanfeng, Hu, Xu, Yin, Xiaoxue, Chen, Yuntian, Chen, Junru, Liu, Haoyang, Liu, Haolin, Liang, Jiayu, Zhang, Xingming, Zhao, Jinge, Zhu, Sha, Ni, Yuchao, Wang, Zhipeng, Dai, Jindong, Wang, Zilin, Zhang, Yaowen, Yao, Jin, Chen, Ni, Shen, Pengfei, Liu, Zhenhua H, Zeng, Hao, Sun, Guangxi X

“…TFE3-rearranged renal cell carcinoma (TFE3-rRCC) is a rare but highly heterogeneous renal cell carcinoma (RCC) entity, of which the clinical treatment…”
Get full text

Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis by Chen, Junru, Zhang, Yaowen, Zhang, Xingming, Zhao, Jinge, Ni, Yuchao, Zhu, Sha, He, Ben, Dai, Jindong, Wang, Zhipeng, Wang, Zilin, Liang, Jiayu, Zhu, Xudong, Shen, Pengfei, Zeng, Hao, Sun, Guangxi

“…Lacking head-to-head trial, the optimal treatment for patients with metastatic castration-resistant prostate cancer (mCRPC) after docetaxel failure is unclear…”
Get full text

The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors by Zhang, Haoran, Zhang, Xingming, Zhu, Xudong, Ni, Yuchao, Dai, Jindong, Zhu, Sha, Sun, Guangxi, Wang, Zhipeng, Chen, Junru, Zhao, Jinge, Zeng, Hao, Li, Zi, Shen, Pengfei

“…Purpose: It remained unclear whether tyrosine kinase inhibitors (TKIs) related renal impairment had impact on the survival of patients with metastatic renal…”
Get full text

The influence of dynamic changes in lipid metabolism on survival outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors by Zhang, Xingming, Zhang, Haoran, Dai, Jindong, Liu, Zhenhua, Zhu, Xudong, Ni, Yuchao, Yin, Xiaoxue, Sun, Guangxi, Zhu, Sha, Chen, Junru, Zhao, Jinge, Wang, Jia, Zeng, Hao, Shen, Pengfei

“…Abstract Background The role of lipid metabolic status in tyrosine kinase inhibitors-treated patients with metastatic renal cell carcinoma is insufficient…”
Get full text

The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer by Zhao, Jinge, Sun, Guangxi, Zhao, Fengnian, Chen, Junru, Zhu, Sha, Xu, Nanwei, Liu, Haoyang, Liang, Jiayu, Hu, Xu, Zhang, Xingming, Ni, Yuchao, Dai, Jindong, Wang, Zhipeng, Shen, Pengfei, Liu, Zhenhua, Chen, Ni, Liu, Jiyan, Zeng, Hao

“…We aim to investigate the prognostic value of different pathological patterns of non-adenocarcinoma prostate cancers (PCa) in radical prostatectomy (RP) and…”
Get full text

Exosomal TUBB3 mRNA expression of metastatic castration‐resistant prostate cancer patients: Association with patient outcome under abiraterone by Zhu, Sha, Ni, Yuchao, Sun, Guangxi, Wang, Zilin, Chen, Junru, Zhang, Xingming, Zhao, Jinge, Zhu, Xudong, Dai, Jindong, Liu, Zhenhua, Liang, Jiayu, Zhang, Haoran, Zhang, Yaowen, Shen, Pengfei, Zeng, Hao

“…Background To use ddPCR to quantify plasma exosomal class III β‐tubulin (βIII‐tubulin, TUBB3, encoded by the TUBB3 gene) mRNA expression in metastatic…”
Get full text

Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based Analysis by Chen, Junru, Ni, Yuchao, Sun, Guangxi, Zhu, Sha, Zhao, Jinge, Wang, Zhipeng, Zhang, Haoran, Zhu, Xudong, Zhang, Xingming, Dai, Jindong, Shen, Pengfei, Zeng, Hao

“…We aimed to compare the efficacy of radical prostatectomy (RP) + extended pelvic lymph node dissection (ePLND) and radiotherapy (RT) in localized prostate…”
Get full text

PD59-11 ASSOCIATION BETWEEN IMMUNE-RELATED ADVERSE EVENTS AND CLINICAL OUTCOMES IN ADVANCED GENITOURINARY CANCERS TREATED WITH IMMUNOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS by Chen, Junru, Zhang, Yaowen, Ni, Yuchao, Sun, Guangxi, Zeng, Hao

Get full text

G9a in Cancer: Mechanisms, Therapeutic Advancements, and Clinical Implications by Ni, Yuchao, Shi, Mingchen, Liu, Liangliang, Lin, Dong, Zeng, Hao, Ong, Christopher, Wang, Yuzhuo

“…G9a, also named EHMT2, is a histone 3 lysine 9 (H3K9) methyltransferase responsible for catalyzing H3K9 mono- and dimethylation (H3K9me1 and H3K9me2). G9a…”
Get full text

MP17-20 EPIGENETIC REGULATOR KMT2C MUTATION DETECTED BY LIQUID BIOPSY IS ASSOCIATED WITH WORSE SURVIVAL IN PROSTATE CANCER PATIENTS by Zhu, Sha, Xu, Nanwei, Zhao, Fengnian, Wang, Zilin, Ni, Yuchao, Dai, Jindong, Zhao, Jinge, Liang, Jiayu, Zhang, Xingming, Chen, Junru, Shen, Pengfei, Zeng, Hao

Get full text

Salsolinol improves angiotensin II‑induced myocardial fibrosis in vitro via inhibition of LSD1 through regulation of the STAT3/Notch‑1 signaling pathway by Zhang, Xian, Shao, Ze, Ni, Yuchao, Chen, Feilong, Yu, Xia, Wen, Jiasheng

“…The clinical incidence of congestive heart failure (CHF) is very high and it poses a significant threat to the health of patients. The traditional Chinese…”
Get full text

The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study by Dai, Jindong, He, Ben, Zhang, Yaowen, Zhang, Haoran, Hu, Xu, Xu, Lijing, Ni, Yuchao, Zhang, Xingming, Sun, Guangxi, Zeng, Hao, Shen, Pengfei, Liu, Zhenhua

“…Purpose The aim of this study was to explore the benefit the metastasectomy for patients with metastatic non-clear cell carcinoma (non-ccRCC). Methods This…”
Get full text

Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer by Zhu, Sha, Ni, Yuchao, Wang, Zilin, Zhang, Xingming, Zhang, Yaowen, Zhao, Fengnian, Dai, Jindong, Wang, Zhipeng, Zhu, Xudong, Chen, Junru, Zhao, Jinge, Zeng, Yuhao, Chen, Ni, Zeng, Peng, Shen, Pengfei, Sun, Guangxi, Zeng, Hao

“…Aldo-keto reductase family 1 member C3 (AKR1C3) is important in prostate cancer progression, being a potential biomarker in metastatic castration-resistant…”
Get full text

Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate by Zhao, Jinge, Sun, Guangxi, Zhu, Sha, Dai, Jindong, Chen, Junru, Zhang, Mengni, Ni, Yuchao, Zhang, Haoran, Shen, Pengfei, Zhao, Xiaochen, Zhang, Bei, Pan, Xiuyi, Nie, Ling, Yin, Xiaoxue, Liang, Jiayu, Zhang, Xingming, Wang, Zhipeng, Zhu, Xudong, Liao, Banghua, Liu, Zhenhua, Armstrong, Cameron M., Gao, Allen C., Huang, Haojie, Chen, Ni, Zeng, Hao

“…Objectives To investigate the genetic alterations of patients with prostate cancer (PCa) with and without intraductal carcinoma of the prostate (IDC‐P)…”
Get full text